BACKGROUND: Hypothermia is one of the most robust experimental neuroprotective interventions against cerebral ischemia. Identification of molecular pathways and gene networks together with single genes or gene families that are significantly associated with neuroprotection might help unravel the mechanisms of therapeutic hypothermia. MATERIAL AND METHODS: We performed a microarray analysis of ischemic rat brains that underwent 90 min of middle cerebral artery occlusion (MCAO) and 48 h of reperfusion. Hypothermia was induced for 4 h, starting 1 h after MCAO in male Wistar rats. At 48 h, magnetic resonance imaging (MRI) was performed for infarct volumetry, and functional outcome was determined by a neuroscore. The brain gene expression profil...
Hypothermia therapy (HT) is used clinically following global cerebral ischemia (GCI) but its therape...
BACKGROUND: A large number of genes are regulated to promote brain repair following stroke. The thor...
Abrupt deprivation of substrates to neuronal tissue triggers a number of pathological events (the “i...
Hypothermia is increasingly used as a therapeutic measure to treat brain injury. However, the cellul...
Mild hypothermia is a promising neuroprotective therapy in stroke management. However, little is kno...
Despite efforts to reduce mortality caused by stroke and perinatal asphyxia, these are still the 2nd...
Hypothermia is increasingly used as a therapeutic measure to treat brain injury. However, the cellul...
SUMMARY Brain ischemia, also termed cerebral ischemia, is a condition in which there is insufficient...
Recent therapeutic trials of novel proteins identified as potentially neuroprotective in animal mode...
OBJECTIVE: Mild hypothermia has a protective effect on ischemic stroke, but the mechanisms remain el...
Hypothermia therapy improves histological and behavioral outcomes and mortality following global cer...
Abstract Background The transient middle cerebral artery occlusion (tMCAO) model is used for studyin...
Abstract Cerebral ischemia is one of the leading causes of disability and mortality worldwide. Blood...
OBJECT: Mild hypothermia is a robust neuroprotectant, and the results of prospective clinical trials...
Background: Altered gene expression is an important feature of ischemic cerebral injury and affects ...
Hypothermia therapy (HT) is used clinically following global cerebral ischemia (GCI) but its therape...
BACKGROUND: A large number of genes are regulated to promote brain repair following stroke. The thor...
Abrupt deprivation of substrates to neuronal tissue triggers a number of pathological events (the “i...
Hypothermia is increasingly used as a therapeutic measure to treat brain injury. However, the cellul...
Mild hypothermia is a promising neuroprotective therapy in stroke management. However, little is kno...
Despite efforts to reduce mortality caused by stroke and perinatal asphyxia, these are still the 2nd...
Hypothermia is increasingly used as a therapeutic measure to treat brain injury. However, the cellul...
SUMMARY Brain ischemia, also termed cerebral ischemia, is a condition in which there is insufficient...
Recent therapeutic trials of novel proteins identified as potentially neuroprotective in animal mode...
OBJECTIVE: Mild hypothermia has a protective effect on ischemic stroke, but the mechanisms remain el...
Hypothermia therapy improves histological and behavioral outcomes and mortality following global cer...
Abstract Background The transient middle cerebral artery occlusion (tMCAO) model is used for studyin...
Abstract Cerebral ischemia is one of the leading causes of disability and mortality worldwide. Blood...
OBJECT: Mild hypothermia is a robust neuroprotectant, and the results of prospective clinical trials...
Background: Altered gene expression is an important feature of ischemic cerebral injury and affects ...
Hypothermia therapy (HT) is used clinically following global cerebral ischemia (GCI) but its therape...
BACKGROUND: A large number of genes are regulated to promote brain repair following stroke. The thor...
Abrupt deprivation of substrates to neuronal tissue triggers a number of pathological events (the “i...